hims compounded glp 1 & Hers stock falls 25% as FDA curtails GLP-1s Hims & Hers Expands Personalized

The FDA decision is anticipated in October 2025

Is Retatrutide treatment for weight loss available in Hollywood, Miami, or West Palm Beach

Phase II Clinical Trials: Efinopegdutide (Merck/Johnson & Johnson/Hanmi Hanma), VK2735 (Viking Therapeutics), BGM0504 (BrightGene), Pemvidutide (Altimmune/Spitfire Pharma), AMG133 (Amgen), Dapiglutide (Zealand Pharma), etc

Suppression of circadian secretion of glucagon-like peptide-1 by the saturated fatty acid, palmitate

However, the privacy policy makes no reference to HIPAA, instead opting for vague language that may or may not mean Lemonaid Health is HIPAA compliant

Since its not yet FDA approved, we dont have a full risk profile of orforglipron